Članci na temu cjepivo protiv korone

A health worker prepares a dose of the AstraZeneca vaccine against Covid-19 during a mass vaccination campaign by SUMMA 112 (Medical Emergency Services of Madrid) at the Wanda Metropolitan stadium in Madrid on February 25, 2021. - So far, some 1.2 million people have been vaccinated in Spain since the start of the immunisation campaign which began just after Christmas with care home residents first in line along with their carers. (Photo by PIERRE-PHILIPPE MARCOU / AFP)
Politika & Kriminal

Izgleda da bi Austrija mogla nastaviti cijepljenje AstraZenecom: 'Treba slušati odluke EMA-e'

Cijepljenje AstraZenecom je obustavilo niz europskih zemalja
Piše Telegram 16. 03. 2021.
A man receives a Pfizer-BioNTech Covid-19 vaccine at a clinic in Belgrade on January 13, 2021. - Serbia has started vaccinating against the novel coronavirus Covid-19 with Pfizer-BioNTech jab on December 24, 2020. The health authorities have also authorised, on December 31, the import of the first doses of the Russian vaccine Sputnik V. (Photo by Vladimir Zivojinovic / AFP)
Politika & Kriminal
Pfizer prilagođava proizvodnju da bi u budućnosti mogli isporučivati 700 milijuna doza više
Piše Hina 15. 01. 2021.
President of Commission Ursula von der Leyen delivers a speech, at European Parliament, in Brussels, on December 16, 2020. (Photo by JOHN THYS / POOL / AFP)
Politika & Kriminal
Kupili smo dovoljno cjepiva za sve u Uniji, tvrdi
Piše Hina 40 preporuka 16. 12. 2020.
A scientist is at work in the VirPath university laboratory, classified as "P3" level of safety, on February 5, 2020 as they try to find an effective treatment against the new SARS-like coronavirus, which has already caused more than 560 deaths. - When most are busy developing vaccines or testing the few anti-virals available, VirPath will go after drugs used for diseases that have nothing to do with a respiratory infection such as 2019-nCoV. (Photo by JEFF PACHOUD / AFP)
Život
Još se ne zna je li neželjeni događaj povezan s lijekom ili cjepivom
Piše Hina 10 preporuka 13. 10. 2020.
Posebne pogodnosti

Specijalni newsletteri za Telegramove pretplatnike.

Najbolje od Telegrama, svaki dan u vašem inboxu.
Kolekcija Telegramovih newslettera
Prijavite se
Odaberite tematske i autorske newslettere koje želite primati.
A scientist is at work in the VirPath university laboratory, classified as "P3" level of safety, on February 5, 2020 as they try to find an effective treatment against the new SARS-like coronavirus, which has already caused more than 560 deaths. - When most are busy developing vaccines or testing the few anti-virals available, VirPath will go after drugs used for diseases that have nothing to do with a respiratory infection such as 2019-nCoV. (Photo by JEFF PACHOUD / AFP)
Život
Studija o cjepivu još nije objavljena, a za sada nema ni nezavisne potvrde
Piše Hina 45 preporuka 13. 06. 2020.